Rheumatoid arthritis is an autoimmune, chronic, inflammatory and systemic disease (that is, a disease that can occur in other systems other than the joints, such as the lungs, heart, skin, viscera, etc.). The disease affects about 1% of the general population, with a higher incidence rate of 3: 1, women, especially 30-50 years of age, while for men the highest incidence occurs in 50-60 years.
The disease is characterized as autoimmune because the body's own immune system, which is responsible for the destruction of "invaders" (eg bacteria and viruses) and cells that are transformed into cancer cells, incorrectly recognizes "foreign" cells of the synovial membrane of the bones that participate in the joints and inflict them, causing inflammatory reactions that are responsible for the clinical manifestations of the disease ranging from simple arthralgia and stiffness (mainly in the morning) to the ignorance of the joints and the installation of chronic disability. Usually small joints of the extremities, especially the fingers, are affected, but any large joint (eg knee or elbow) can be affected.
Approximately 18% of patients with Rheumatoid Arthritis (PA) also show concomitant mental disorders, with more frequent Depression and Generalized Anxiety Disorder, while research data associate RA with increased rates of suicide.
The disease itself, therefore, seems to cause depressive and anxiety manifestations, but depression and intense stress can act as triggering and aggravating factors of the disease. This vicious circle influences the prognosis and course of rheumatoid disease and is a prime example of the bi-directional relationship of the immune system on both the central nervous system and the "mental organ" on the other. Depression and stressful conditions have been found to affect functional and immune system disorders, and inflammatory factors are involved in the onset of psychiatric and neuroendocrine pathological events.
The underlying causes of neuropsychiatric disorders that may accompany the onset of Rheumatoid Arthritis can be justified both because of the direct attack by the disease (or by the agents used to treat it) of the Central Nervous System (ie the brain itself, as this disease may, as mentioned above, also have extraarticular manifestations in various systems of the organism, other than the musculoskeletal) and due to the psychological reactions the disease itself, because of the pain it caused, the general load of body symptoms and the change in the somatoscope of the sufferers it mentions.
Indeed, Rheumatoid Arthritis, in particular in its severe forms, erodes the patient's daily routine, reducing his ability to respond to his socio-economic roles (eg in his work and interpersonal relationships). The catastrophic view of the possible progression of the disease and the fear of establishing chronic disability and / or articular malformations affects both the patient's psychology and the development of the disease itself, essentially functioning as a "self-fulfilling prophecy" of deterioration.
Breaking the vicious circle of fear into the course of RA, depression and aggravation of the disease
Simply put, the patient or the Rheumatoid Arthritis sufferer is afraid of the progression of the disease, hurts the affected joints, is saddened and anxious about his negative impact on his daily routine and body image, resulting in the released catecholamines and the stimulation of the Sympathetic Nervous System to affect the immune response, leading to the final, actual, worsening of the inflammatory disease.
It is therefore very important to have early psychiatric and psychological intervention in patients with RA in order to deal with the depressive and anxiety disorders that accompany it and eliminate the cognitive distortions about its sure and permanent deterioration that develop on the path of the disease and finally are self-confirmed through the aforementioned vicious cycle presented schematically below:
Depression + anxiety -> immune -> inflammatory joint reaction (PA aggravation) -> pain + functional decline in everyday life -> depression + anxiety.
Although international bibliographic data remains controversial, there are studies associating interventions of cognitive type psychotherapy with improved values of specific biological markers of Rheumatoid arthritis, such as C-reactive protein, rheumatoid factor and anti-CCP antibodies.
Pharmaceutical interventions in rheumatoid arthritis, from a psychiatric perspective
Although complete and definitive treatment of Rheumatoid Arthritis has not been found, with the latter remaining essentially a "life-long disease" with exacerbations and recessions, we now have several therapeutic regimens that slow down the progression of RA and minimize joint damage, an important parameter is the faster initiation of Pharmacy (PA) after diagnosis of the disease to ensure the best possible results of limiting joint damage, pain and conjunctions of the adverse effects on the quality of life of patients.
Drugs used to treat rheumatoid arthritis belong to one of the following main categories, each of which may affect the mental manifestations of patients. However, it is stressed that despite the possible psychiatric side effects of the formulations, this should not in any case be dissuasive in taking and / or continuing the medication, the responsibility for which the treating physician rheumatoid is regulated.
Specifically:
Painkillers: They should not be abused, especially if preparations containing paracetamol and codeine, a substance belonging to opioids, are used, as the latter are implicated in both addictive and immunomodulatory phenomena.
Non-steroidal anti-inflammatory: They are mainly administered to relieve pain and swelling of the joints, but are taken in high doses for emotional disturbances, delirium and aggression.
Corticosteroids (Cortisone): Although they do not fully cure the disease, they suppress it to a significant extent in most cases, as they are very effective in reducing inflammation. From a psychiatric point of view, cortisone is implicated in emotional disorders (mainly depressive type), psychotic manifestations and delirium.
Anti-rheumatic, disease-modifying drugs: These are drugs that target the disease itself and not its symptoms. They are distinguished in synthetic and biological agents, intervening directly in the inflammatory mechanisms of RA, resulting in the modification of its prognosis and the inhibition of its progression. Azathioprine has been shown to be adverse effects of dermal manifestations such as cyclosporin, which is also associated with the appearance of anxiety symptoms, while Hydoxichlorocin is involved in some cases in the induction of behavioral and emotional disorders as well as psychotic and confusing episodes
The bilateral relationship of depression with the onset of Rheumatoid Arthritis is thus revealed by studies showing an increase in the incidence of Major Depressive Disorder in Rheumatoid Arthritis Patients and related studies that show an increase in the relative risk of RA, of 38% in people with Major Depressive Disorder. This increase is justified, not only by the association of neuropsychiatric pathology with the mechanisms of inflammation and immune, but also because depression pushes the individual into adopting more unhealthy life patterns, such as limited physical exercise, poor eating habits, and smoking, agents who are implicated in the development of Rheumatoid Arthritis.
The bilateral relationship of depression with the onset of Rheumatoid Arthritis is thus revealed by studies showing an increase in the incidence of Major Depressive Disorder in Rheumatoid Arthritis Patients and related studies that show an increase in the relative risk of RA, of 38% in people with Major Depressive Disorder. This increase is justified, not only by the association of neuropsychiatric pathology with the mechanisms of inflammation and immune, but also because depression pushes the individual into adopting more unhealthy life patterns, such as limited physical exercise, poor eating habits, and smoking, agents who are implicated in the development of Rheumatoid Arthritis.
However, this risk of PA manifestation appears to be declining in those patients with Major Depressive Disorder receiving antidepressant treatment, which reveals the importance of the role of psychiatric follow-up in patients with rheumatic diseases, if - in our case - we consider that depressive relapses have been found to be associated with PA outbursts.
The incidence of mental disorders in patients with RA is affected by psychosocial, physical and genetic factors. The low economic level and the lack of adequate social and family support systems increase the risk of experiencing mental disorder in PA patients. In particular, low sociability, intense pain and family history of mental illness predispose patients to an increased risk of depression in PA sufferers, while the same applies to poverty and poor social support that burden the onset of anxiety disorders in the same patients .
Studies have shown that serotoninergic pathways of the nervous system play an important role in regulating "inflammatory pain" as compared to "mechanical" pain. Antidepressants such as venlafaxine and duloxetine, which block receptors and serotonin and noradrenaline, also exhibit analgesic properties. Tricyclic antidepressants have long been used in rheumatology clinics because of their positive effects on patients' pain, mood and sedation. Venlafaxine, Fluoxetine and citalopram (the latter two being inhibitors of serotonin re-uptake receptors-SSRIs) have yielded results in experimental models of mice with arthritis,
In conclusion, the correlation of psychological factors and immunological pathology expresses the close functional interaction of the nervous system with the immune system by imposing the holistic, psychosomatic treatment of Rheumatoid Arthritis sufferers and underlining the importance of appropriate psychopharmaceutical and psychodynamic interventions in this particular group of autoimmune diseases, as appropriate psychiatric intervention can not only alleviate the mental and physical pain of and RA patients, but also to change radically, for the better development of the disease itself.

No comments:
Post a Comment